Physical Performance Following Hematopoietic Stem Cell Transplantation: A Prospective Observational Study

被引:0
|
作者
Rindflesch, Aaron B. [1 ,2 ]
Hake, Melissa P. [1 ,2 ]
Spiten, Megan A. [1 ,2 ]
Trueblood, Jinise K. [1 ,2 ]
Reiplinger, Allison F. [1 ,2 ]
Dykstra, Rebecca L. [1 ,2 ]
Hollman, John H. [1 ,2 ]
机构
[1] Mayo Clin, Coll Med & Sci, Sch Hlth Sci, Program Phys Therapy, Rochester, MN USA
[2] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA
关键词
comorbidity; functional performance; hematopoietic stem cell transplantation; longitudinal studies; recovery of function; COMORBIDITY INDEX; CANCER-PATIENTS; EXERCISE; RELIABILITY; STRENGTH; THERAPY; FATIGUE; FRAILTY; RISK;
D O I
10.1097/01.REO.0000000000000203
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Purpose/Objective: Patients undergoing hematopoietic stem cell transplantation (HSCT) are at risk for strength impairments and activity limitations. Research describing how HSCT affects physical performance is limited. The purposes of this study were to report the short-term (<= 30 days) effects of HSCT on physical performance and to compare changes among patients during the engraftment and recovery periods following HSCT. Methods: Design: Prospective observational study. Setting: Academic medical center. Patients: Twenty-five adults 21 years and older undergoing HSCT. Intervention: None. Measurements: Measures were collected at 3 time points: (1) day of transplant; (2) 8 to 14 days posttransplant; and (3) 15 to 30 days posttransplant. Beside demographic data, the authors collected Short Physical Performance Battery (SPPB) scores, Functional Comorbidity Index scores, resting heart rate, and hospitalization status. Longitudinal changes in SPPB scores were analyzed with a generalized linear model (alpha = 0.05). Results: SPPB scores were negatively associated with patients' body mass index values and resting heart rate measurements. Additionally, the hospitalization x time interaction was statistically significant. SPPB scores among nonhospitalized patients remained consistent across the testing periods but among hospitalized patients decreased from the day of transplant to both the 8 to 14 days (mean change = 4.0 points) and 15 to 30 days (mean change = 4.1 points) posttransplant time points. Conclusion: Physical performance scores decreased in the first 30 days of recovery among patients who were hospitalized following HSCT, but not among patients who received transplant on an outpatient basis. Future studies to examine causes of and interventions for the reduction in physical performance among hospitalized patients post-HSCT are warranted.
引用
收藏
页码:122 / 126
页数:5
相关论文
共 50 条
  • [21] Prospective Study of Total Body Irradiation as Pretreatment for Hematopoietic Stem Cell Transplantation
    Ishibashi, N.
    Maebayashi, T.
    Sakaguchi, M.
    Aizawa, T.
    Saito, T.
    Tanaka, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S682 - S683
  • [22] Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation
    Buxbaum, Nataliya Prokopenko
    Pavletic, Steven Z.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [23] Cytomegalovirus reactivation following hematopoietic stem cell transplantation
    Sharma, Sanjeev Kumar
    Kumar, Suman
    Agrawal, Narendra
    Singh, Lavleen
    Mukherjee, Anjan
    Seth, Tulika
    Mishra, Pravas
    Mathur, Sandeep
    Dar, Lalit
    Mahapatra, Manoranjan
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2013, 7 (12): : 1003 - 1007
  • [24] Toxoplasmosis following allogeneic hematopoietic stem cell transplantation
    Rodrigo Martino
    Catherine Cordonnier
    Bone Marrow Transplantation, 2003, 31 : 617 - 618
  • [25] Lymphoid reconstitution following hematopoietic stem cell transplantation
    Hollander, Georg A.
    SEMINARS IN IMMUNOPATHOLOGY, 2008, 30 (04) : 369 - 370
  • [26] Vitiligo Following Autologous Hematopoietic Stem Cell Transplantation
    Nguyen, James
    Singh, Navdeep
    Afifi, Salma
    Giralt, Sergio
    Lacouture, Mario E.
    Busam, Klaus J.
    Hassoun, Hani
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (04): : E171 - E173
  • [27] Pyoderma gangrenosum following hematopoietic stem cell transplantation
    Eddou, H.
    Ennouhi, A.
    Sina, M.
    Zinebi, A.
    El Benaye, J.
    Moudden, M. K.
    Doghmi, K.
    Malfuson, J-, V
    Mikdame, M.
    El Baaj, M.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2018, 145 (6-7): : 445 - 450
  • [28] Abdominal Complications Following Hematopoietic Stem Cell Transplantation
    del Campo, Lourdes
    Gomez Leon, Nieves
    Castano Palacios, Diana
    Lagana, Claudio
    Tagarro, David
    RADIOGRAPHICS, 2014, 34 (02) : 396 - +
  • [29] Pulmonary Complications Following Hematopoietic Stem Cell Transplantation
    Sossa Melo, Claudia Lucia
    Ines Jimenez, Sara
    Antonio Salazar, Luis
    Maria Pena, Angela
    Rosales, Manuel
    Alfonso Machado, Carlos
    Marcela Chalela, Claudia
    Lucrecia Luna-Gonzalez, Maria
    Leonardo Reyes, David
    Serrano Gomez, Sergio
    Enrique Ochoa, Miguel
    Garay, Jennifer
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [30] DYSLIPIDEMIA FOLLOWING PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Marron, J. M.
    Kharbanda, S.
    Craveiro, L.
    Balise, R. R.
    Agarwal, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S257 - S257